...
首页> 外文期刊>PLoS Biology >Authorization of Animal Experiments Is Based on Confidence Rather than Evidence of Scientific Rigor
【24h】

Authorization of Animal Experiments Is Based on Confidence Rather than Evidence of Scientific Rigor

机译:动物实验的授权基于信任而不是科学严谨的证据

获取原文
           

摘要

Accumulating evidence indicates high risk of bias in preclinical animal research, questioning the scientific validity and reproducibility of published research findings. Systematic reviews found low rates of reporting of measures against risks of bias in the published literature (e.g., randomization, blinding, sample size calculation) and a correlation between low reporting rates and inflated treatment effects. That most animal research undergoes peer review or ethical review would offer the possibility to detect risks of bias at an earlier stage, before the research has been conducted. For example, in Switzerland, animal experiments are licensed based on a detailed description of the study protocol and a harm–benefit analysis. We therefore screened applications for animal experiments submitted to Swiss authorities ( n = 1,277) for the rates at which the use of seven basic measures against bias (allocation concealment, blinding, randomization, sample size calculation, inclusion/exclusion criteria, primary outcome variable, and statistical analysis plan) were described and compared them with the reporting rates of the same measures in a representative sub-sample of publications ( n = 50) resulting from studies described in these applications. Measures against bias were described at very low rates, ranging on average from 2.4% for statistical analysis plan to 19% for primary outcome variable in applications for animal experiments, and from 0.0% for sample size calculation to 34% for statistical analysis plan in publications from these experiments. Calculating an internal validity score (IVS) based on the proportion of the seven measures against bias, we found a weak positive correlation between the IVS of applications and that of publications (Spearman’s rho = 0.34, p = 0.014), indicating that the rates of description of these measures in applications partly predict their rates of reporting in publications. These results indicate that the authorities licensing animal experiments are lacking important information about experimental conduct that determines the scientific validity of the findings, which may be critical for the weight attributed to the benefit of the research in the harm–benefit analysis. Similar to manuscripts getting accepted for publication despite poor reporting of measures against bias, applications for animal experiments may often be approved based on implicit confidence rather than explicit evidence of scientific rigor. Our findings shed serious doubt on the current authorization procedure for animal experiments, as well as the peer-review process for scientific publications, which in the long run may undermine the credibility of research. Developing existing authorization procedures that are already in place in many countries towards a preregistration system for animal research is one promising way to reform the system. This would not only benefit the scientific validity of findings from animal experiments but also help to avoid unnecessary harm to animals for inconclusive research. Author Summary Scientific validity of research findings depends on scientific rigor, including measures to avoid bias, such as random allocation of animals to treatment groups (randomization) and assessing outcome measures without knowing to which treatment groups the animals belong (blinding). However, measures against bias are rarely reported in publications, and systematic reviews found that poor reporting was associated with larger treatment effects, suggesting bias. Here we studied whether risk of bias could be predicted from study protocols submitted for ethical review. We assessed mention of seven basic measures against bias in study protocols submitted for approval in Switzerland and in publications resulting from these studies. Measures against bias were mentioned at very low rates both in study protocols (2%–19%) and in publications (0%–34%). However, we found a weak positive correlation, indicating that the rates at which measures against bias were mentioned in study protocols predicted the rates at which they were reported in publications. Our results indicate that animal experiments are often licensed based on confidence rather than evidence of scientific rigor, which may compromise scientific validity and induce unnecessary harm to animals caused by inconclusive research.
机译:越来越多的证据表明在临床前动物研究中存在偏见的高风险,质疑已发表研究结果的科学有效性和可重复性。系统评价发现已发表文献中针对偏倚风险的措施报告率较低(例如随机化,盲法,样本量计算),并且报告率较低与治疗效果过高之间存在相关性。大多数动物研究都经过同行评审或道德审查,这为在进行研究之前及早发现偏见风险提供了可能性。例如,在瑞士,根据实验方案的详细说明和危害效益分析,对动物实验进行了许可。因此,我们筛选了提交给瑞士当局(n = 1,277)的动物实验应用,以评估使用七种基本偏倚措施(分配隐瞒,盲目化,随机化,样本量计算,纳入/排除标准,主要结果变量,和统计分析计划)进行了描述,并将它们与这些申请中所述研究的代表性出版物子样本(n = 50)中相同度量的报告率进行了比较。针对偏倚的措施的描述率非常低,在动物实验应用中,平均值从统计分析计划的2.4%到主要结果变量的19%,从样本量计算的0.0%到出版物中的统计分析计划的34%不等。从这些实验中。根据针对偏倚的七项衡量指标的比例计算内部有效性评分(IVS),我们发现应用程序的IVS与出版物的IVS之间存在较弱的正相关性(Spearman的rho = 0.34,p = 0.014),表明在应用程序中对这些措施的描述部分地预测了它们在出版物中的报告率。这些结果表明,授权动物实验的主管部门缺乏确定实验结果科学有效性的有关实验行为的重要信息,这可能对危害效益分析中研究收益的重要性至关重要。类似于手稿,尽管对偏倚措施的报告不多,但仍被接受出版。动物实验的申请通常可能基于内隐的信任而不是科学严谨的明确证据而被批准。我们的发现严重质疑当前的动物实验授权程序以及科学出版物的同行评审过程,从长远来看,这可能会损害研究的可信度。制定许多国家针对动物研究预注册系统的现有授权程序,是改革该系统的一种有前途的方法。这不仅有利于动物实验结果的科学有效性,而且还有助于避免因无定论的研究而对动物造成不必要的伤害。作者摘要研究结果的科学有效性取决于科学的严谨性,包括避免偏差的措施,例如将动物随机分配到治疗组(随机化)和评估结果量度而不知道动物属于哪个治疗组(致盲)。但是,在出版物中很少报道有针对偏倚的措施,而系统评价发现,较差的报道与更大的治疗效果相关,这表明存在偏倚。在这里,我们研究了是否可以从提交伦理审查的研究方案中预测偏见的风险。我们评估了在瑞士提交待批准的研究方案以及这些研究产生的出版物中提及的七项基本措施,以防止偏差。在研究方案(2%–19%)和出版物(0%–34%)中,提及偏倚措施的比率都非常低。但是,我们发现了弱的正相关性,表明研究方案中提到的针对偏倚的措施的发生率预测了出版物中报道这些措施的发生率。我们的结果表明,动物实验通常是基于置信度而不是科学严谨性的证据进行许可的,这可能会损害科学的有效性,并因不确定的研究而对动物造成不必要的伤害。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号